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Abstract
Background: Studies of the apoptosis mechanisms involved in the pathogenesis of tuberculosis have suggested
that Mycobacterium tuberculosis can actively interfere with the apoptosis of infected cells. In vivo studies have been
performed in adult populations but have not focused on this process in children. In the present study, we analyzed
spontaneous T lymphocyte (PBT) apoptosis in the peripheral blood of children with central nervous system
tuberculosis (CNS TB), before and after chemotherapy, and compared the results with healthy controls.
Methods: A case-control study was conducted from January 2002 to June 2009. It included 18 children with CNS
TB and 17 healthy controls. Spontaneous apoptosis of PBTs, including CD4
+, CD8
+ and CD8
+/CD28
+ T cells, was
evaluated after 24 and 72 h of culture in complete medium, using the Annexin V detection test. Analysis was
conducted before and after chemotherapy, and expression of the apoptotic markers CD95 (Fas) and Fas ligand
(FasL) was evaluated.
Results: Higher percentages of apoptotic T cells and CD4 lymphocytes were isolated from children with acute phase
CNS TB than from children in the control group (p < 0.05). This difference significantly decreased after 60 days of
specific treatment. In children with CNS TB, high levels of Fas ligand expression were detected in lymphocyte
populations, associated with a high percentage of Fas positive cells, before and after treatment. In contrast to the CD4+
apoptosis profile, we did not find any significant difference in total CD8
+ cell apoptosis between children with acute
phase disease and the control group. However, the percentage of apoptotic CD8
+/CD28
+ T cells was significantly
higher in the children with acute phase disease than in the healthy controls.
Conclusions: Our findings indicate that CNS TB in pediatric patients increases the sensitivity of CD4 and CD8
+/CD28
+ T
cells to apoptosis, suggesting a hypoergic status of this infection. This could play a key role in the immunopathogenesis
of this complicated form of TB. Interestingly, specific chemotherapy is able to normalize both apoptosis sensitivity and
T-cell activation.
Background
Pediatric tuberculosis (TB) remains one of the most
important communicable diseases and represents a
major health problem in the developing world. Globally,
approximately 1 million new cases and approximately
500,000 deaths due to pediatric TB are reported every
year [1,2].
In Italy, similar to many other industrialized nations,
TB is a relatively rare disease. In the last few years, the
incidence of TB has been less than 10 cases/100,000
population (in 2009 the rate was 7/100,000 population,
corresponding to just over 4,200 cases) while according
to WHO estimates, the prevalence of latent infections is
12% (corresponding to just over 7,200,000 latent infec-
tions) [1].
While 90% of immunocompetent adult patients
infected by the tubercle bacillus will not develop the dis-
ease during their lifetime, children have shown various
clinical forms of infection and progressive disease [2,3].
Although pulmonary TB tends to be the most common
form of TB, TB of the central nervous system (CNS)
carries the highest mortality and morbidity rates and
develops in 4% of infected children, especially during
infancy [4-6].
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too immature to stimulate a host protective response
against intracellular pathogen growth. Some progress
towards understanding the mechanism involved in
immune responses to Mycobacterium tuberculosis infec-
tion has been made by studying adult patients. However,
other aspects need to be assessed through research in
pediatric populations. The relevant role of apoptosis
(programmed cell death) in the development of the
immune system in children has recently been high-
lighted in studies on the efficacy of the TB vaccine [7,8].
Recent studies have demonstrated that M. tuberculosis
actively interferes with the apoptosis of infected cells in
vitro as a means of virulence, and that dysregulation of the
host’s lipid metabolism is a major pathway for generating
pathology and promoting necrosis over apoptosis [9,10].
However, the importance of apoptosis as a virulence
mechanism in vivo and interaction of apoptotic mechan-
isms with the host cytokine response have been largely
unexplored until recently, with this area of research slowly
being understood [10-12].
A number of alternative mechanisms of peripheral T cell
apoptosis have been defined. The distinction has been
made between active apoptosis, which follows stimulation
and activation of the T cells, and passive apoptosis, which
occurs as a result of withdrawal of the sustaining cytokines
following activation [13-16]. Activation of death receptors
by their ligands can initiate apoptosis. Fas and Tumor
Necrosis Factor (TNF) receptors are more clearly under-
stood than others, and their important role in peripheral T
cell apoptosis has been demonstrated. The Fas/Fas ligand
(FasL) interaction is particularly important in initiating
activation induced cell death of CD4
+ T cells [17-20].
Understanding the specific mechanisms by which chil-
dren’s T cells fail to contain Mycobacterium TB infection
could offer potential new targets for appropriate vaccines.
In addition, studying the defects in infant immune
responses that explain poor bacterial control may contri-
bute more broadly to our understanding of severe forms
of TB such as CNS TB.
In this study, we analyzed spontaneous T lymphocyte
(PBT) apoptosis and the subsets CD3+, CD4+ and CD8+,
including the analysis of apoptotic CD8
+/CD28
+ T cells, in
the peripheral blood of children with CNS TB, before and
after starting anti tubercular treatment and compared
them with healthy control children.
Methods
Subjects
Eighteen children with CNS TB (10 boys, 8 girls; mean age
[± SD], 3.8 years [3.4]; range, 0.5-12 years] admitted to the
G. Di Cristina Children’s Hospital in Palermo, Italy, were
selected according to Centers for Disease Control (CDC)
Case Definition clinical and/or microbiological criteria
between January 2002 and December 2009 [21].
Diagnosis was bacteriologically confirmed by polymerase
chain reaction (PCR) and/or culture of M. tuberculosis
complex in CSF samples and/or CSF culture, as previously
reported [22,23]. CSF culture and PCR were positive in
60% and 90% of patients, respectively. Resistant strains to
1o rm o r ea n t i - T Bd r u g sw e r ef o u n di n4c h i l d r e na n d
their adult sources.
Seven patients (38%) had pulmonary TB. The source of
infection was documented for 9 patients (50%): it was
grandparents for 4 patients, parents for 3 patients, a tea-
cher for 1 patient, and a neighbor for 1 patient.
All of the children received antitubercular treatment
for 1 year, consisting of 2 months of isoniazid (INH),
rifampicin (RMP), pyrazinamide (PZA) and streptomycin
(SM) or ethambutol (ETB), followed by 10 months of
RMP and INH [24].
All the subjects enrolled in the study were negative for
human immunodeficiency virus (HIV).
A control group comprised 17 healthy children who
were Purified Protein Derivative (PPD) skin test negative
(10 boys and 7 girls; mean age [± SD], 5.6 years [3.2];
range, 2-12 years). The study protocol was approved by
the Ethics Committee of the G. Di Cristina Hospital in
Palermo (Italy) and informed consent was sought in accor-
dance with the principles of the Declaration of Helsinki.
Patients were thoroughly informed about the procedures
and written informed consent was obtained from each of
them. Peripheral blood was drawn from children with
CNS TB during the acute phase of illness, and 30-60 days
and 90 days after starting chemotherapy. The follow-up
time point after the start of antitubercular therapy was
chosen on the basis of previous studies conducted by our
group [22,25,26].
Isolation of peripheral blood mononuclear cells (PBMCs)
PBMCs were isolated by Ficoll-Paque density centrifuga-
tion from 20 mL of heparinized blood drawn from chil-
dren with CNS-TB and from the healthy children in the
control group.
PBMC cultures: PBMCs were cultured in RPMI 1640
medium supplemented with 10% FCS at 37°C in a humi-
dified atmosphere of 5% CO2 [27,28].
Apoptosis detection and PBT phenotype analysis
T cell spontaneous apoptosis was determined after 24 and
72 h of culture in complete medium, using the Annexin V
detection kit as previously described [27,28]. Apoptotic
cells were identified by means of double or triple staining
with an Annexin V-FITC kit (Bender MedSystem, Vienna,
Austria) and anti-human peridinin chlorophyll protein-
CD3 (Becton Dickinson, San Jose, CA, USA), and anti-
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Glostrup, Denmark) or anti-human RPE-conjugated CD4
clone MT310 (Dakopatts). T lymphocytes were also inves-
tigated for their expression of CD28 (Dakopatts). Cell
apoptosis and the phenotype of PBTs were determined
with a FACSCalibur Plus flow cytometer (Becton Dickin-
son). Phycoerythrin-conjugated (X-928, Dakopatts) and
FITC-conjugated mouse anti-human IgG1 (X-927, Dako-
patts) were used as negative controls.
Fas and Fas-L expression
Fas and FasL expression were evaluated by flow cytometry
(Becton Dickinson) using antihuman PE-conjugated CD95
and antihuman FITC conjugated CD95L (Dakopatts)
MoAbs. PE-conjugated (X-928, Dakopatts) and FITC-con-
jugated mouse antihuman IgG1 (X-927, Dakopatts) were
used as negative controls. Fas and FasL expressions are
shown as the percentage of positive cells.
Statistical analysis
Discrete variables were analyzed using the chi-square and
Fisher’s exact tests, as needed. The independent Student’st
test and the Mann-Whitney U statistic test were used for
parametric and non-parametric analysis, respectively. The
paired-samples Student’s t-test and paired Wilcoxon
signed-rank test were used for intragroup parametric and
non-parametric analysis, respectively. All statistical tests
were two-tailed and were applied at the 5% significance
level. Data were analyzed with Epi Info software, version
3.2.2 (Centers for Disease Control and Prevention, Atlanta,
Georgia, USA) and SPSS software (version 14.0; SPSS Inc.,
Chicago, IL, USA).
Results
T lymphocytes, Fas and FasL during CNS TB
The mean (± SD) total lymphocyte and CD3
+ lympho-
cyte counts in peripheral blood of patients in the acute
phase of disease and in controls are shown in Table 1.
There were no significant differences between the 2
groups (p > 0.05).
Spontaneous apoptosis of PBTs isolated from CNS TB
patients and from the healthy controls was evident after
24 h (p < 0.0005), and steadily increased after 72 h (p <
0.0005).
There was a significant increase in apoptotic CD3
+
lymphocytes in the children with acute phase CNS TB
after 24 (p < 0.0005) and 72 h of incubation compared
with those in the control group (p < 0.0005). This
increased sensitivity in CD3
+ lymphocytes to apoptosis
was still evident after 30-60 days of specific anti-tuber-
cular therapy, but it was decreased in children treated
for more than 90 days (Figure 1).
Fas and FasL expression was significantly higher in the
T lymphocytes of children with acute phase CNS TB
than that in healthy control group children after 24 and
72 h of incubation (p < 0.0005, Figure 2a, b). This differ-
ence was still evident in patients treated for 30-60 days
(Fas and FasL after 24 h, p = 0.010, p < 0.0005; Fas and
FasL after 72 h, p < 0.0005, p < 0.0005), but it was
decreased in children treated for more than 90 days (Fas
and FasL after 24 h of incubation, p > 0.05, p = 0.024;
Fas and FasL after 72 h of incubation, p = 0.003, p =
0.025; Figure 2a, b).
T Lymphocyte subset apoptosis during CNS TB
The mean (± SD) CD4
+, CD8
+ and CD8
+/CD28
+ T lym-
phocyte counts in patients during the acute phase of the
disease and in the controls are shown in Table 1. There
were no significant differences between the 2 groups
(p > 0.05).
Spontaneous apoptosis was evaluated in different CD3
+
lymphocyte subpopulations (CD4
+,C D 8
+)o fp a t i e n t s
affected by CNS TB and in children in the control group.
Table 1 Peripheral blood lymphocyte populations* in
acute CNS TB children and uninfected children (controls)
Acute phase Controls P-value
Lymphocytes (× 10
9/l) 6.77(3.6) 6.58(2.8) 0.863
CD3+ T -lymphocytes (× 10
9/l) 6.20(3.2) 5.11(2.1) 0.245
CD4+ T -lymphocytes (× 10
9/l) 2.17(1.2) 2.28(0.8) 0.753
CD8+ T -lymphocytes (× 10
9/l) 1.33(0.6) 1.09(0.4) 0.176
CD28+ T -lymphocytes (× 10
9/l) 0.36(0.2) 0.27(0.1) 0.105
* mean values (± SD)
Figure 1 Apoptosis in T-lymphocytes from uninfected children
(controls), and children with CNS tuberculosis before and after
specific treatment, at the different time periods. Apoptosis was
induced in vitro within 24 h (solid line) and after 72 h of culture in
complete medium (dashed line).
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+ T-lymphocytes isolated
from the TB children before treatment showed a greater
sensitivity towards apoptosis than those of the control
group (acute vs control after 24 and 72 h of incubation,
p = 0.019 and p < 0.0005, respectively). This difference
was decreased after 30-60 days of antitubercular treatment
(after 24 and 72 h of incubation, p = 0.027 and p = 0.035,
respectively) and disappeared after 90 days (acute vs con-
trol after 24 and 72 h of incubation, p > 0.05).
Comparative analysis of apoptosis in CD8
+ lymphocyte
populations in acute phase CNS TB children treated for
30-60 days and for more than 90 days and in the con-
trols showed no significant differences after 24 and 72 h
of incubation (p > 0.05).
Analysis of apoptotic CD8
+/CD28
+ T cells showed
impaired cell apoptosis in the acute phase of disease
(acute vs control after 24 and 72 h of incubation, p <
0.0005 and p = 0.002, respectively). The difference
between CNS TB patients and healthy control children
decreased after 90 days of specific treatment (p > 0.05,
Figure 4).
Discussion
The results of our study show that PBTs isolated from
children with CNS TB had a stronger apoptotic response
and underwent apoptosis more rapidly than those of
healthy subjects, even after 3 months of antitubercular
treatment. These responses were due to high levels of
FaL expression in lymphocyte populations. Moreover, the
number of Fas positive cells remained high even after
starting treatment for TB. The reason for these findings
may be because Koch’s bacillus produces or induces sub-
stances in macrophages that increase the sensitivity of
lymphocytes to apoptosis by increasing Fas expression or
Fas-L for protection against antitubercular activity [9,29].
We did not find any significant difference in the absolute
number of T lymphocytes and their subsets in the
Figure 2 Fas (2a) and FasL (2b) expression during central nervous system tuberculosis in the illness group, before and after specific
treatment at the different time periods, and in uninfected children (controls). Results are shown as percentage of Fas and FasL -expressing
cells among T-lymphocytes after 24 h (solid line) or within 72 h of culture in complete medium (dashed line).
Figure 3 Apoptosis in CD4
+ T cells from children with CNS
tuberculosis, before and after specific treatment at the
different time periods, and from uninfected children (controls).
Results are shown as percentage of CD4
+ T cells after 24 h (solid
line) or within 72 h of culture in complete medium (dashed line).
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controls. A previous study of adult pulmonary TB patients
showed a significantly lower percentage of CD3
+ and
CD4
+ cells, and a significantly lower ratio of CD4
+ and
CD8
+ cells compared with healthy controls [30].
CD4
+ cells are critical in immunity against M. tuber-
culosis infection. CD4+ T lymphocytes play 2 important
roles in TB infection: first, they produce cytokines that
govern cell-mediated immune responses; and second,
they eliminate infected macrophages via apoptosis
[31-33].
The relevant role of CD4
+ cells in the pathogenesis of
CNS TB is confirmed by CD4
+ cell counts and TB menin-
gitis in the HIV population [33]. We observed a high per-
centage of CD4
+ T lymphocyte apoptosis in our study
population, both in the acute phase of disease and after
the start of specific treatment. Therefore, CD4 depletion
by apoptosis is a foreseeable phenomenon in TB patients.
In fact, we found that patients with a more severe form of
TB had CD4
+ lymphocyte depletion despite their CD4
+
cell counts. In contrast to the CD4
+ apoptosis profile, we
did not find any significant difference in CD8
+ cell apopto-
sis between children with CNS TB and the control group.
This could be the consequence of increased CD4
+ lym-
phocyte apoptosis through the Fas/FasL system.
CD8
+ T cells can efficiently eradicate TB infection by
inducing apoptosis of infected cells, and this cell death
is mainly, but not always, mediated via the Tumor
Necrosis Factor Receptors (TNFR) [17,34,35]. The
hypoergic status of CD8 T cells and the increased sus-
ceptibility of CD4 T cells to apoptosis may be induced
by specific cytokines produced during infection to avoid
an immunological response against Koch’s bacillus
[14,35]. Although different M. tuberculosis specific CD8
+T cell subsets, such as CD27
+ and CD28
+ (activated T
cells), may be involved in these mechanisms, their role
is not well understood in pediatric patients [31,36].
Interestingly, CD8
+/CD28
+ T cell apoptosis was signif-
icantly lower in the children with CNS TB before che-
motherapy, suggesting a protective role of these cells in
response to M. tuberculosis infection. Contrasting results
have been reported in other studies. Both increases and
decreases in levels of CD8
+/CD28
+ T cells in peripheral
blood have been detected in adult patients with active
TB compared with healthy controls [36,37]. However,
further studies are required to elucidate the mechanisms
of these phenomena.
Our study suggests that TB infection in children
increases the sensitivity of CD4
+ T lymphocytes to apop-
tosis and causes a decrease in CD8
+ activated T lympho-
cytes. Interestingly, chemotherapy was able to normalize
both apoptosis sensitivity and T cell activation. This
c o u l dp l a yak e yr o l ei nt h ei m m u n ep a t h o g e n e s i so ft h e
disease. Involvement of the CNS is a serious complica-
tion of TB and is most frequent in children aged between
6 months and 6 years, although it can occur at any age
[4,5]. Ten of the children in our study population were in
this age range. Consequently, our data may help the
understanding of what type of immune response against
the tubercle bacillus is activated in the first year of life.
Conclusions
To our knowledge, this is the only study to date to eval-
uate apoptosis in T lymphocytes from children with
CNS TB. A better understanding of apoptosis regulation
in TB is required to develop new immune-based thera-
pies aimed at modulating apoptosis in infected patients.
Considering the current, very poor laboratory support
for the diagnosis and management of childhood TB,
further studies with large numbers of subjects are
required to define the clinical value of these assays.
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